After Cancer – Sexual Health Specialist Course

Published on: 08/27/24

Current Status
Not Enrolled
Price
$675.
Get Started

This sexual health specialist course will improve provider knowledge and confidence related to addressing and screening for sexual health side effects in patients impacted by cancer. This course includes 14.25 hours of content. 

Patients benefit when their providers normalize the conversation, set expectations, evaluate and treat common concerns in the clinic, and refer to other specialists timely when necessary.

©2023 After Cancer

Accreditation Information

LEARNING OBJECTIVES

 

  1. List the six components of the 30-second message all patients should hear after a cancer diagnosis.
  2. Identify three common health side effects caused by cancer or its treatment.
  3. Identify two professional specialists who are common referral sources for patients impacted by cancer.
SPEAKER INFORMATION

 

Laila Agrawal, MD
Hematologist/Oncologist, Breast Medical Oncology, Norton Healthcare

Erika Allred
Professional Voice Actor

Rodrigo Bayon, MD
Clinical Associate Professor of Otolaryngology, Roy J. and Lucille A. Carver College of Medicine, University of IowaOtolaryngologist, University of Iowa Hospitals and Clinics

  • HPV Related Oropharyngeal Cancer

Lauren Broschak, MSW, LCSW, OSW-C
Oncology-Certified Licensed Clinical Social Worker, Life with Cancer

  • Cancer and Sexual Desire
  • Cancer and Sexual Self-Schema
  • Cancer and Sexual Relationships

Marloe Esch RN, BSN, OCN
Breast Care Nurse Navigator, Froedtert Hospital

  • Supporting the Sexual Health Needs of Adolescent and Young Adult (AYA) Cancer Patients

Elizabeth Graf, PA-C
Physician Assistant, University of Iowa Hospitals and Clinics

  • The Pain-Focused Pelvic Exam
  • Advanced Treatment of Female Problems

Nikki Goff DNP, ARNP, RN, WHNP-BC
Certified Women’s Health Nurse Practitioner, University of Iowa Hospitals and Clinics

  • Surveillance of Gynecologic Cancer

Alexandra Hill, PT, DPT, WCS, CLT-LANA
Pelvic Health and Oncology Physical Therapist, UF Health Jacksonville

  • The Role of Pelvic Health PT for the Management of Cancer-Related Sexual Dysfunction

Emily Hill, MD
Clinical Associate Professor of Obstetrics and Gynecology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Gynecologic Oncologist, University of Iowa Hospitals and Clinics

Jordan Hill, PharmD, BCOP
Oncology Pharmacy Specialist (Breast Cancer), West Virginia University Medicine

  • Sexual Health and Cancer-Potential Pharmacologic Causes and Recommended Management

Susan Kaliszewski, PA-C
Physician Assistant, University of Iowa Hospitals and Clinics

  • LGBTQ+ Patients-Unique Risk Factors and Sexuality Concerns
  • Practical Pointers for the LGBTQ+ Patient in Cancer Care

Veronika Kolder, MD
Obstetrics and Gynecology Specialist, Iowa City, IA

Michele Lewis, RN
“All of Me project volunteer”

Mandy Mindin, MS, RD, CD
Oncology and Clinical Inpatient Registered Dietitian, Ascension

  • Nutrition in the Oncology Setting

Ken Mitchell, MPAS, PA-C
Men’s Reproductive and Sexual Health Specialist, Arkansas Urology

  • Addressing Sexual Health is Valuable to a Practice
  • Post Prostate Cancer Treatment-Erection Restoration

Maxwell Mowitz
Program Director, One Iowa

  • Practical Pointers for the LGBTQ+ Patient in Cancer Care

Stacey Pawlak, PhD
Clinical Associate Professor of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, University of Iowa

  • Clinical Psychologist, University of Iowa Hospitals and Clinics

Amy Pearlman, MD
Urologist, Prime Institute

  • Evaluating the Patient with Erectile Problems
  • Treatment of Erectile Dysfunction After Prostate Cancer
  • Sexual Dysfunction and Treatment in Males

Erin Sullivan-Wagner
Executive Director, After Cancer

  • Normalizing the Conversation – The 30-Second Message
  • Challenging Scenarios
  • Evaluating the Patient with Sexual Health Problems
  • Setting Patient Expectations

Emily Wentzell, PhD
Associate Professor of Anthropology, University of Iowa

  • Supporting Sexual Health without Stereotypes

Ann Wolf, ARNP
Nurse Practitioner, Program Director Breast and Plastic Surgery, Iowa City VA Health Care System

  • Care of the Breast Cancer Patient
CONTACT INFORMATION

 

For any comments or questions, please reach out to Erin Sullivan-Wagner

  • Erin@aftercancer.co
CONTINUING EDUCATION INFORMATION

 

Des Moines University is the accredited continuing education provider. This activity has been approved for AMA PRA Category 1 Credit(s)™, American Osteopathic Association credit, nursing contact hours, and continuing education contact hours. If you have questions regarding credit, please email cme@dmu.edu.

ACCREDITATION STATEMENTS

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and After Cancer, Inc. DMU designates this live activity for 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 14.25 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 14.25 continuing education contact hour(s). Nurses must attend the entire session to receive credit. Partial session credit is prohibited and will be forfeited.
  • Other healthcare providers: This live activity is designated for 14.25 AMA PRA Category 1 Credit(s)™.

 

EDUCATIONAL GRANTS: No ineligible company provided financial support for this continuing education activity.

 

DISCLOSURE: The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.

 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Erika Allred – Narrator
  • Rodrigo Bayon, MD – Speaker
  • Lauren Broschak, MSW, LCSW, OSW-C – Planning Committee Member and Speaker
  • Marloe Esch RN, BSN, OCN – Speaker
  • Nikki Goff DNP, ARNP, RN, WHNP-BC – Speaker
  • Emily Hill, MD – Speaker
  • Susan Kaliszewski, PA-C – Speaker
  • Veronika Kolder, MD – Planning Committee Member and Speaker
  • Michele Lewis, RN – Speaker
  • Mandy Mindin, MS, RD, CD – Speaker
  • Ken Mitchell, MPAS, PA-C – Speaker
  • Maxwell Mowitz – Speaker
  • Stacey Pawlak, PhD – Speaker
  • Erin Sullivan-Wagner – Activity Director and Speaker
  • Emily Wentzell, PhD – Speaker
  • Ann Wolf, ARNP – Speaker

 

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.

 

  • Laila Agrawal, MD – Speaker
    • Honoraria: Pfizer, Astra Zeneca, Breast Cancer Index – Ad Boards
    • Speaker’s Bureau: Lilly
    • The relationships are not relevant to the content of this educational activity.
  • Elizabeth Graf, PA-C – Speaker
    • Does not have a financial relationship to disclosure; however, does intend to discuss off-label uses of the following commercial product(s)/device(s).
  • Alexandra Hill, PT, DPT, WCS, CLT-LANA – Speaker
    • Affiliate Link Partner: Intimate Rose, Ohnut, and Soul Source
  • Jordan Hill, PharmD, BCOP – Speaker
    • Does not have a financial relationship to disclosure; however, does intend to discuss off-label uses of the following commercial product(s)/device(s).
  • Amy Pearlman, MD – Speaker
    • Consultant: EndoPharmaceuticals
    • Grant or Research Support: Boston Scientific
    • Medical Advisory Board: FirmTech
    • Intends to discuss off-label uses of the following commercial product(s)/device(s).

 

DISCLAIMER: The information provided in this activity is for continuing education purposes only. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

 

Recording date: April 2021 to August 2023

Date of original release: December 15, 2023

Most recent review/update: December 15, 2023

Next review date: September 2024